chronic obstructive pulmonary disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Comply with the diagnostic criteria of COPD patients; 2. Conform to the lung and kidney deficiency syndrome; 3. Degree of condition of mild, moderate and severe patients with plateau; 4. At the age of 40 age 75 years old or less or less; 5. Rounding out the top one month does not attend other interventions in clinical research; 6. Voluntary treatment, and sign the informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients with acute aggravating period of COPD; 2. Belongs to very severe COPD patients with plateau condition; 3. Do not meet above TCM syndrome types; 4. Pregnancy and lactation women; 5. Delirious, dementia, all kinds of mental illness; 6. Cardiac function grade ? and hemodynamic instability; 7. Combination of bronchiectasis, bronchial asthma, active tuberculosis, occlusive bronchiolitis, diffuse bronchiolitis, pleural effusion, pulmonary embolism, pneumothorax patients; 8. The neuromuscular diseases affect respiratory movement function; 9. Merger of tumor; 10. Severe liver and kidney diseases (severe liver disease refers to cirrhosis, portal hypertension and varices bleeding, severe kidney disease including dialysis, kidney transplantation); 11. A variety of reasons in long-term; 12. Rounding out the top 1 months of oral corticosteroids; 13. Congenital or acquired immune deficiency; 14. Taking part in clinical subjects of other drugs, known for treatment of drug allergy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of COPD exacerbations;pulmonary function; | — |
Secondary
| Measure | Time frame |
|---|---|
| clinical symptoms;Evaluation of TCM symptomatology;mrc dyspnea scale;six-minute walk distance;quality of life;Drug combination situation; | — |
Countries
China